PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of heartHeartVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Heart. 1996 February; 75(2): 159–164.
PMCID: PMC484252

Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure.

Abstract

OBJECTIVE: To evaluate the efficacy and safety of the second generation dihydropyridine calcium channel blocker lacidipine in patients with heart failure. DESIGN: Placebo controlled, parallel group, double blind study over 8 weeks. SETTING: General community hospital in Breda, The Netherlands. PATIENTS: A random sample was studied of 25 outpatients with symptoms of mild to moderate heart failure, despite treatment with diuretics, digoxin, and angiotensin converting enzyme inhibitors. Their mean age was 65 years, with mean left ventricular ejection fraction of 0.24 and a peak oxygen consumption of 14.4 ml/min/kg. Two patients dropped out on lacidipine, one patient on placebo. INTERVENTION: Treatment with lacidipine 4 mg once daily or placebo for eight weeks. MAIN OUTCOME MEASURE: Cardiopulmonary exercise testing, invasive haemodynamics, and plasma neurohormones. RESULTS: Treatment with lacidipine 4 mg once daily, as compared to placebo treatment, significantly improved peak oxygen consumption (P < 0.02), cardiac index (P < 0.01), and stroke volume (P < 0.03) paralleled by a decrease in systemic vascular resistance (P < 0.03) and arteriovenous oxygen content difference (P < 0.01). Plasma noradrenaline, plasma renin activity, and aldosterone values did not differ between lacidipine and placebo. CONCLUSIONS: This second generation dihydropyridine may be of value as an adjunct to standard treatment in congestive heart failure patients.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cohn JN. The prevention of heart failure--a new agenda. N Engl J Med. 1992 Sep 3;327(10):725–727. [PubMed]
  • Packer M. Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy. Circulation. 1990 Dec;82(6):2254–2257. [PubMed]
  • Elkayam U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation. 1990 Dec;82(6):1954–1961. [PubMed]
  • NAIMARK A, WASSERMAN K, MCILROY MB. CONTINUOUS MEASUREMENT OF VENTILATORY EXCHANGE RATIO DURING EXERCISE. J Appl Physiol. 1964 Jul;19:644–652. [PubMed]
  • Burow RD, Strauss HW, Singleton R, Pond M, Rehn T, Bailey IK, Griffith LC, Nickoloff E, Pitt B. Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography. Circulation. 1977 Dec;56(6):1024–1028. [PubMed]
  • Dunselman PH, Kuntze CE, van Bruggen A, Beekhuis H, Piers B, Scaf AH, Wesseling H, Lie KI. Value of New York Heart Association classification, radionuclide ventriculography, and cardiopulmonary exercise tests for selection of patients for congestive heart failure studies. Am Heart J. 1988 Dec;116(6 Pt 1):1475–1482. [PubMed]
  • Kassis E, Amtorp O. Long-term clinical, hemodynamic, angiographic, and neurohumoral responses to vasodilation with felodipine in patients with chronic congestive heart failure. J Cardiovasc Pharmacol. 1990 Mar;15(3):347–352. [PubMed]
  • Schofer J, Hobuss M, Aschenberg W, Tews A. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study. Eur Heart J. 1990 Aug;11(8):712–721. [PubMed]
  • Dunselman PH, Kuntze CE, van Bruggen A, Hamer JP, Scaf AH, Wessling H, Lie KI. Efficacy of felodipine in congestive heart failure. Eur Heart J. 1989 Apr;10(4):354–364. [PubMed]
  • Tan LB, Murray RG, Littler WA. Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects. Br Heart J. 1987 Aug;58(2):122–128. [PMC free article] [PubMed]
  • Kassis E, Amtorp O. Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure. Circulation. 1987 Jun;75(6):1204–1213. [PubMed]
  • Cody RJ, Franklin KW, Kluger J, Laragh JH. Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril. Am J Med. 1982 May;72(5):791–797. [PubMed]
  • Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation. 1989 Jul;80(1):65–77. [PubMed]
  • van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, Withagen AJ, Pasteuning WH, Brouwer J, Lie KI. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol. 1993 Nov 15;22(6):1564–1573. [PubMed]
  • Bonnier HJ, Visser RF, Klomps HC, Hoffmann HJ. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. Am J Cardiol. 1988 Jul 1;62(1):25–30. [PubMed]
  • Firth BG, Dehmer GJ, Markham RV, Jr, Willerson JT, Hillis LD. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes. Am J Cardiol. 1982 Nov;50(5):954–959. [PubMed]
  • Haq A, Rakowski H, Baigrie R, McLaughlin P, Burns R, Tihal H, Hilton D, Feiglin D. Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies. Am J Cardiol. 1982 Feb 1;49(2):439–444. [PubMed]
  • Koolen JJ, Van Wezel HB, Piek J, van Liebergen R, Swaan A, Visser CA. Effects of intracoronary felodipine versus nifedipine on left ventricular contractility and coronary sinus blood flow in stable angina pectoris. Am J Cardiol. 1994 Oct 1;74(7):730–732. [PubMed]
  • Elkayam U, Weber L, McKay C, Rahimtoola S. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. Am J Cardiol. 1985 Sep 15;56(8):560–566. [PubMed]
  • Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993 Jul;88(1):107–115. [PubMed]

Articles from Heart are provided here courtesy of BMJ Group